The budget impact of endoscopic screening for esophageal varices in cirrhosis.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 17905009)

Published in Gastrointest Endosc on October 01, 2007

Authors

Brennan M R Spiegel1, Eric Esrailian, Glenn Eisen

Author Affiliations

1: Greater Los Angeles Healthcare System, David Geffen School of Medicine at UCLA, UCLA/VA Center for Outcomes Research and Education (CORE), 11301 Wilshire Blvd, Bldg 115 Rm 215, Los Angeles, CA 90073, USA.

Articles by these authors

Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc (2005) 3.23

Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology (2008) 3.11

Utilization of upper endoscopy for surveillance of gastric ulcers in the United States. Am J Gastroenterol (2008) 2.14

Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol (2010) 2.02

Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository. Gastroenterology (2004) 1.88

Assessment of the quality of colonoscopy reports: results from a multicenter consortium. Gastrointest Endosc (2009) 1.64

Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis. J Fam Pract (2002) 1.61

Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States. Clin Gastroenterol Hepatol (2005) 1.55

Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol (2008) 1.44

Grading the complexity of endoscopic procedures: results of an ASGE working party. Gastrointest Endosc (2011) 1.39

An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc (2008) 1.32

Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States. J Hepatol (2004) 1.20

Age- and sex-specific yield of Barrett's esophagus by endoscopy indication. Gastrointest Endosc (2009) 1.17

A prospective study of the diagnostic accuracy of PillCam ESO esophageal capsule endoscopy versus conventional upper endoscopy in patients with chronic gastroesophageal reflux diseases. J Clin Gastroenterol (2005) 1.14

Do indication and demographics for colonoscopy affect completion? A large national database evaluation. Eur J Gastroenterol Hepatol (2010) 1.10

Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. Clin Gastroenterol Hepatol (2008) 1.08

A closer look at same-day bidirectional endoscopy. Gastrointest Endosc (2008) 1.02

Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0. Hepatology (2007) 0.99

Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort. Am J Gastroenterol (2009) 0.95

The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review. Hemodial Int (2009) 0.93

Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs. Arthritis Rheum (2002) 0.92

Identifying and reporting risk factors for adverse events in endoscopy. Part I: cardiopulmonary events. Gastrointest Endosc (2011) 0.92

Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis. CNS Drugs (2007) 0.90

A multicenter, prospective, randomized comparison of a novel signal transmission capsule endoscope to an existing capsule endoscope. Gastrointest Endosc (2013) 0.89

Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc (2007) 0.89

Identifying and reporting risk factors for adverse events in endoscopy. Part II: noncardiopulmonary events. Gastrointest Endosc (2011) 0.87

A nationwide 2010-2012 analysis of U.S. health care utilization in inflammatory bowel diseases. Inflamm Bowel Dis (2014) 0.83

Barrett's esophagus on repeat endoscopy: should we look more than once? Am J Gastroenterol (2008) 0.83

Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy. Am J Gastroenterol (2002) 0.82

Combined endoscopic and laparoscopic surgery may be an alternative to bowel resection for the management of colon polyps not removable by standard colonoscopy. Surg Endosc (2013) 0.82

Acid-related upper endoscopy findings in patients with diabetes versus non-diabetic patients. Dig Dis Sci (2010) 0.79

Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact. Inflamm Bowel Dis (2015) 0.75

Multisociety guideline on reprocessing flexible GI endoscopes: 2016 update. Gastrointest Endosc (2017) 0.75

Multisociety guideline on reprocessing flexible GI endoscopes: 2016 update. Gastrointest Endosc (2017) 0.75

In Memoriam: Lauren Battat Gerson, MD, MS. Gastrointest Endosc (2017) 0.75

Defining a Patient Population With Cirrhosis: An Automated Algorithm With Natural Language Processing. J Clin Gastroenterol (2016) 0.75

Turn, Turn, Turn-it's time to turn over the reins at GIE. Gastrointest Endosc (2014) 0.75

VideoGIE - launch! Gastrointest Endosc (2013) 0.75

The impact of value-based healthcare for inflammatory bowel diseases on healthcare utilization: a pilot study. Eur J Gastroenterol Hepatol (2016) 0.75